HypGen Inc
Change company Symbol lookup
Select an option...
HPGN HypGen Inc
IX Orix Corp
WHR Whirlpool Corp
PG Procter & Gamble Co
PWJAX PGIM Jennison International Opportunities Fund- Class A
MBWM Mercantile Bank Corp
MEIUF Meitu Inc
HD Home Depot Inc
ACC American Campus Communities Inc
MRLN Marlin Business Services Corp

Company profile

HypGen Inc., formerly Mega Bridge Inc., is a clinical-staged biotechnology company. The Company through its platform is focused on development and commercialization of Phorbol 12-myristate 13-acetate (PMA) internal i.d. RP-323, a focused immunotherapy and stem cell activator for treating neurological diseases (CNS). The Company is entering into phase II clinical study for developing treatments for neurological and Parkinson’s disease at cellular level. Parkinson’s disease is a progressive, degenerative neurological disease, resulting from degeneration of neurons in a region of the brain that controls movement.

Closing Price
Day's Change
B/A Size
Day's High
Day's Low

UPDATE: Viacom's streaming service Paramount Plus makes its debut

11:47 am ET March 4, 2021 (MarketWatch)

By Weston Blasi

Here's what to know about the new streaming service Paramount Plus

Another streaming service is here.

Paramount Plus, the new streaming service from CBS parent company Viacom (VIAC), has launched. It's a rebranding of CBS All Access, and it ran several ads during the Super Bowl (https://www.marketwatch.com/story/heres-everything-you-need-to-know-about-betting-on-the-super-bowl-legally-11612206906) featuring a cast of characters whose content will be featured on the service, including Patrick Stewart, Dora the Explorer, Stephen Colbert and SpongeBob SquarePants.

Paramount Plus (https://www.paramountplus.com/) is absorbing the CBS All Access service, while adding new content from Comedy Central, Nickelodeon and Paramount movies.

The official price for Paramount Plus is $5.99 a month with ads and $9.99 a month ad-free. The new streaming service will eventually be the home for original content like the Halo TV series, Star Trek: Strange New Worlds and a Frasier reboot.

CBS All Access was trending during this year's Super Bowl as it suffered an embarrassing outage (https://www.marketwatch.com/story/cbs-all-access-fumbles-its-super-bowl-livestream-crashing-before-kickoff-11612744412), crashing just before the game started.

When subscribers tried to watch the game, they received an error message reading: "Uh oh. An error has occurred, but we're working on fixing it. We'll be up and running again shortly!"

See also: (https://www.marketwatch.com/story/if-you-blinked-you-probably-missed-reddits-super-bowl-commercial-11612749779)Square to take majority stake in Tidal streaming service (https://www.marketwatch.com/story/square-to-take-majority-stake-in-tidal-streaming-service-11614864984?mod=home-page)

The streaming industry has grown increasingly robust in recent years. Paramount Plus will be competing with streamers like AT&T's (T) HBO Max, Netflix (NFLX), Amazon (AMZN), Disney (DIS) Apple (AAPL) and Hulu.

Check out MarketWatch's streaming tool to find the "true" cost of streaming services (https://www.marketwatch.com/story/before-you-sign-up-for-disney-this-calculator-adds-up-the-true-cost-of-your-streaming-services-2019-11-13).

-Weston Blasi; 415-439-6400; AskNewswires@dowjones.com


(END) Dow Jones Newswires

March 04, 2021 11:47 ET (16:47 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.